open access

Vol 20, No 4 (2015)
Original research articles
Published online: 2015-07-01
Submitted: 2014-11-03
Get Citation

Volumetric modulated arc therapy in prostate cancer patients with metallic hip prostheses in a UK centre

Wee Loon Ng, John Brunt, Simon Temple, Mohammed Saipillai, Anoop Haridass, Helen Wong, Zafar Malik, Chinnamani Eswar
DOI: 10.1016/j.rpor.2015.03.006
·
Rep Pract Oncol Radiother 2015;20(4):273-277.

open access

Vol 20, No 4 (2015)
Original research articles
Published online: 2015-07-01
Submitted: 2014-11-03

Abstract

Aim

This study aimed to investigate whether IMRT using VMAT is a viable and safe solution in dose escalated RT in these patients.

Background

An increasing number of prostate cancer patients are elderly and have hip prostheses. These implants pose challenges in radiotherapy treatment planning. Although intensity modulated radiotherapy (IMRT) is commonly used, there is a lack of clinical studies documenting its efficacy and toxicities in this subgroup of patients.

Materials and methods

The data from 23 patients with hip prostheses and non-metastatic prostate cancer treated with VMAT (volumetric modulated arc therapy) between 2009 and 2011, were retrospectively analyzed. Baseline characteristics, treatment details and outcome data were collected on all patients. The median follow up was 40.9 months. MRI-CT image fusion was performed and the treatment plans were created using RapidArc™ (RA) techniques utilizing 1 or 2 arcs and 10[[ce:hsp sp="0.25"/]]MV photon beams.

Results

96% of patients were treated with a dose of 72[[ce:hsp sp="0.25"/]]Gy/32 fractions over 44 days. 21/23 plans met the PTV targets. The mean homogeneity index was 1.07. 20/23 plans met all OAR constraints (rectum, bladder). Two plans deviated from rectal constraints, four from bladder constraints; all were classed as minor deviations. One patient experienced late grade 3 genitourinary toxicity. Three other patients experienced late grade 2 or lower gastrointestinal toxicity. One patient had biochemical failure and one had a non-prostate cancer related death.

Conclusions

VMAT provides an elegant solution to deliver dose escalated RT in patients with unilateral and bilateral hip replacements with minimal acute and late toxicities.

Abstract

Aim

This study aimed to investigate whether IMRT using VMAT is a viable and safe solution in dose escalated RT in these patients.

Background

An increasing number of prostate cancer patients are elderly and have hip prostheses. These implants pose challenges in radiotherapy treatment planning. Although intensity modulated radiotherapy (IMRT) is commonly used, there is a lack of clinical studies documenting its efficacy and toxicities in this subgroup of patients.

Materials and methods

The data from 23 patients with hip prostheses and non-metastatic prostate cancer treated with VMAT (volumetric modulated arc therapy) between 2009 and 2011, were retrospectively analyzed. Baseline characteristics, treatment details and outcome data were collected on all patients. The median follow up was 40.9 months. MRI-CT image fusion was performed and the treatment plans were created using RapidArc™ (RA) techniques utilizing 1 or 2 arcs and 10[[ce:hsp sp="0.25"/]]MV photon beams.

Results

96% of patients were treated with a dose of 72[[ce:hsp sp="0.25"/]]Gy/32 fractions over 44 days. 21/23 plans met the PTV targets. The mean homogeneity index was 1.07. 20/23 plans met all OAR constraints (rectum, bladder). Two plans deviated from rectal constraints, four from bladder constraints; all were classed as minor deviations. One patient experienced late grade 3 genitourinary toxicity. Three other patients experienced late grade 2 or lower gastrointestinal toxicity. One patient had biochemical failure and one had a non-prostate cancer related death.

Conclusions

VMAT provides an elegant solution to deliver dose escalated RT in patients with unilateral and bilateral hip replacements with minimal acute and late toxicities.

Get Citation

Keywords

Arc; Hip; Prosthesis; Prostate; Radiotherapy; VMAT

About this article
Title

Volumetric modulated arc therapy in prostate cancer patients with metallic hip prostheses in a UK centre

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 20, No 4 (2015)

Pages

273-277

Published online

2015-07-01

DOI

10.1016/j.rpor.2015.03.006

Bibliographic record

Rep Pract Oncol Radiother 2015;20(4):273-277.

Keywords

Arc
Hip
Prosthesis
Prostate
Radiotherapy
VMAT

Authors

Wee Loon Ng
John Brunt
Simon Temple
Mohammed Saipillai
Anoop Haridass
Helen Wong
Zafar Malik
Chinnamani Eswar

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl